CME Group Inc. (NASDAQ:CME) Announces Quarterly Dividend of $1.15

CME Group Inc. (NASDAQ:CME) announced a quarterly dividend on Thursday, November 7th,RTT News reports. Investors of record on Monday, December 9th will be paid a dividend of 1.15 per share by the financial services provider on Friday, December 27th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date is Monday, December 9th.

CME Group has raised its dividend by an average of 9.0% annually over the last three years and has increased its dividend every year for the last 14 years. CME Group has a payout ratio of 44.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect CME Group to earn $10.24 per share next year, which means the company should continue to be able to cover its $4.60 annual dividend with an expected future payout ratio of 44.9%.

CME Group Price Performance

NASDAQ:CME opened at $225.66 on Friday. The firm has a market cap of $81.26 billion, a PE ratio of 23.73, a price-to-earnings-growth ratio of 5.61 and a beta of 0.55. The company’s 50-day moving average price is $221.72 and its two-hundred day moving average price is $209.91. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group has a 12 month low of $190.70 and a 12 month high of $230.36.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the business posted $2.25 earnings per share. On average, equities analysts anticipate that CME Group will post 10.23 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on CME shares. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. Barclays boosted their price target on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. The Goldman Sachs Group raised their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. Finally, Piper Sandler increased their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $222.73.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.